Yanyan Liu

This study is for people with a rare type of blood cancer called peripheral T-cell lymphoma. It tests whether a new combination of two targeted drugs (linperlisib and chidamide) works better than standard chemotherapy. The goal is to shrink tumors and keep the cancer under contro…